|
Any hearing loss Crude OR (95 % CI)
|
Any hearing loss aaOR (95 % CI)
|
Less severe hearing loss aaOR (95 % CI)
|
More severe hearing loss aaOR (95 % CI)
|
---|
Kanamycin
|
Reference
|
Reference
|
Reference
|
Reference
|
Amikacin
|
2.3 (1.2–4.6)
|
2.3 (1.0–5.4)
|
1.6 (0.6–4.5)
|
4.0 (1.5–10.8)
|
- Legend: aOR adjusted odds ratio, aadjusted for patient age, treatment site and year of treatment initiation; 95%CI =95 % confidence interval. Note that baseline body weight band, sex, human immunodeficiency virus infection status were not adjusted for because they were potential effect-modifiers (see Table 5)